Dr. Laura Jelliffe-Pawlowski, PhD, is an Associate Professor of Epidemiology & Biostatistics in the UCSF School of Medicine and is the Director of Precision Health and Discovery with the UCSF California Preterm Birth Initiative. Dr. Jelliffe-Pawlowski and her team work to identify new tools, tests and technologies that can help identify pregnant women and babies at increased risk for preterm birth, complications of prematurity, and associated birth defects and developmental delays. She has a particular focus and interest in work that leverages molecular markers to help predict outcomes and identify in-roads for intervention and has developed tests to predict preterm birth, metabolically date babies at birth, and tests to predict survival and severe complications in vulnerable babies. She leads cohort studies in the United States and Africa that focus on vulnerable populations of color with the aim of uncovering and addressing cell-to-society drivers of pregnancy and newborn complications.
Researchers have long been recognizing the uniqueness of women’s health and the substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared with men. This session will include the effect of women’s health on the following topics: